Botox Maker Settles Case for $600 Million

Botox Maker Settles Case for $600 Million
New York Times Blog
September 1, 2010

The New York Times was one of the first national publications to report on the $600 million settlement of Nolan Auerbach’s qui tam case against Allergan. “The significance of the case is that Allergan promoted Botox for off-label uses, uses that were not approved by the FDA as being safe and effective,” said Marcella Auerbach, managing partner of Nolan Auerbach.

OUR PROMISE Being a healthcare whistleblower can feel like David taking on Goliath. We help level the playing field.

Our law practice is dedicated exclusively to representing healthcare whistleblowers who are willing to take a stand against unscrupulous corporations that are ripping off our government. Whether the fraud involves __________, we pride ourselves on unparalleled level of service, support and legal assistance for our clients.
Contact Us